Eric Burks, MD
Clinical Associate Professor
Boston University Chobanian & Avedisian School of Medicine

MD, University of New Mexico School of Medicine
BS, New Mexico State University

Eric Burks, MD is a Clinical Associate Professor of Pathology at the Chobanian and Avedisian School of Medicine. After graduating medical school, he had two fellowship: one in Surgical Pathology at Harvard Medical School and another in Hematopathology at Johns Hopkins Medical Institution. Only recently, as of April 2018, did he join Boston University. With him he brings extensive experience as a lecturer, mentor, and physician. His research is particularly notable given that he has received both the American Cancer Society Institutional Research Grant Medical Student Award and the American Society of Hematology Medical Student Award.

Boston University
BU-BMC Cancer Center

Integrating imaging and biopsy-derived molecular markers for the pre-surgical detection of indolent and aggressive early stage lung adenocarcinoma
07/10/2023 - 06/30/2028 (PI)
Trustees of Boston University, BUMC National Cancer Inst


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Zheng Y, Conrad RD, Green EJ, Burks EJ, Betke M, Beane JE, Kolachalama VB. Graph attention-based fusion of pathology images and gene expression for prediction of cancer survival. IEEE Trans Med Imaging. 2024 Apr 08; PP.View Related Profiles. PMID: 38587959
  2. Gindra RH, Zheng Y, Green EJ, Reid ME, Mazzilli SA, Merrick DT, Burks EJ, Kolachalama VB, Beane JE. Graph Perceiver Network for Lung Tumor and Bronchial Premalignant Lesion Stratification from Histopathology. Am J Pathol. 2024 Apr 06.View Related Profiles. PMID: 38588853; DOI: 10.1016/j.ajpath.2024.03.009;
  3. Ma L, Sullivan TB, Rieger-Christ KM, Yambayev I, Zhao Q, Higgins SE, Yilmaz OH, Sultan L, Servais EL, Suzuki K, Burks EJ. Vascular invasion predicts the subgroup of lung adenocarcinomas =2.0 cm at risk of poor outcome treated by wedge resection compared to lobectomy. JTCVS Open. 2023 Dec; 16:938-947.View Related Profiles. PMID: 38204657; PMCID: PMC10775162; DOI: 10.1016/j.xjon.2023.11.003;
  4. Jamil ML, Perecman A, Sherman A, Sullivan T, Christ K, Hansma A, Burks E, Vanni AJ. Urinary microbiome differences between lichen sclerosus induced and non-lichen sclerosus induced urethral stricture disease. World J Urol. 2023 Sep; 41(9):2495-2501. PMID: 37421420
  5. Suaiti L, Sullivan TB, Rieger-Christ KM, Servais EL, Suzuki K, Burks EJ. Vascular Invasion Predicts Recurrence in Stage IA2-IB Lung Adenocarcinoma but not Squamous Cell Carcinoma. Clin Lung Cancer. 2023 May; 24(3):e126-e133. PMID: 36631388
  6. Zheng Y, Gindra RH, Green EJ, Burks EJ, Betke M, Beane JE, Kolachalama VB. A Graph-Transformer for Whole Slide Image Classification. IEEE Trans Med Imaging. 2022 Nov; 41(11):3003-3015.View Related Profiles. PMID: 35594209; PMCID: PMC9670036; DOI: 10.1109/TMI.2022.3176598;
  7. Prokaeva T, Klimtchuk ES, Feschenko P, Spencer B, Cui H, Burks EJ, Aslebagh R, Muneeruddin K, Shaffer SA, Varghese E, Berk JL, Connors LH. An additive destabilising effect of compound T60I and V122I substitutions in ATTRv amyloidosis. Amyloid. 2023 Jun; 30(2):141-152.View Related Profiles. PMID: 36286264
  8. Kalantzakos TJ, Sebel LE, Trussler J, Sullivan TB, Burks EJ, Sarita-Reyes CD, Canes D, Moinzadeh A, Rieger-Christ KM. MicroRNA Associated with the Invasive Phenotype in Clear Cell Renal Cell Carcinoma: Let-7c-5p Inhibits Proliferation, Migration, and Invasion by Targeting Insulin-like Growth Factor 1 Receptor. Biomedicines. 2022 Sep 28; 10(10).View Related Profiles. PMID: 36289686; PMCID: PMC9598558; DOI: 10.3390/biomedicines10102425;
  9. Yambayev I, Sullivan TB, Rieger-Christ KM, Servais EL, Stock CT, Quadri SM, Sands JM, Suzuki K, Burks EJ. Vascular invasion identifies the most aggressive histologic subset of stage I lung adenocarcinoma: Implications for adjuvant therapy. Lung Cancer. 2022 Sep; 171:82-89.View Related Profiles. PMID: 35932520; DOI: 10.1016/j.lungcan.2022.07.016;
  10. Prokaeva T, Joshi T, Klimtchuk ES, Gibson VM, Spencer B, Siddiqi O, Nedelkov D, Hu Y, Berk JL, Cuddy SAM, Dasari S, Chiu A, Choate LA, McPhail ED, Cui H, Chen H, Burks EJ, Sanchorawala V, Connors LH. A novel substitution of proline (P32L) destabilises ß2-microglobulin inducing hereditary systemic amyloidosis. Amyloid. 2022 Dec; 29(4):255-262.View Related Profiles. PMID: 35575118; DOI: 10.1080/13506129.2022.2072199;
Showing 10 of 50 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 50 publications over 15 distinct years, with a maximum of 13 publications in 2021


Contact for Mentoring:

670 Albany Street
Boston MA 02118
Google Map

Burks's Networks
Click the "See All" links for more information and interactive visualizations
Similar People